Global High Content Screening (HCS) Industry

NEW YORK, Aug. 30, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global High Content Screening (HCS) Industry

http://www.reportlinker.com/p0960435/Global-High-Content-Screening-HCS-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

This report analyzes the worldwide markets for High Content Screening (HCS) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 50 companies including many key and niche players such as BD Biosciences, BioTek Instruments Inc., CompuCyte Corporation, CM Technologies Oy, Definiens AG, EMD Millipore, EVOTEC BioSystems, Essen BioScience, Fluxion Biosciences, Inc., GE Healthcare Life Sciences, Genedata AG, IntelliCyt Corporation, Life Technologies Corporation, Molecular Devices Inc., PerkinElmer Inc., Roche Applied Science, Thermo Fisher Scientific, Inc., TTP LabTech Ltd., and Yokogawa Electric Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

To order this report:Drug_Discovery_and_Development Industry: Global High Content Screening (HCS) Industry

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker